Litcius/Paper detail

In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase

İsmail Çeli̇k, Meryem Erol, Zekeriya Düzgün

2021Molecular Diversity45 citationsDOIOpen Access PDF

Topics & Concepts

FavipiravirRNA polymeraseRNA-dependent RNA polymerasePolymeraseIn silicoRibavirinChemistryDocking (animal)Drug repositioningDrugRNAEbola virusVirologyPharmacologyBiochemistryBiologyEnzymeVirusCoronavirus disease 2019 (COVID-19)MedicineGeneNursingHepatitis C virusDiseasePathologyInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyComputational Drug Discovery Methods
In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase | Litcius